Protein Apex1 Found Key to Autoimmune Treatment
Researchers identify Apex1 protein as a promising target for autoimmune disease treatment.
Sara is a credited writer, editor, contributor, and essayist, as well as a novelist and poet with more than two decades of experience in media arts. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara is a member of the International Association of Writers & Editors, has received numerous awards and has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She is also a mental health therapist, clinical supervisor and entrepreneur, holding an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling (graduating with a 4.2/4.0 GPA). Additionally, she is a member of Chi Sigma Iota, was on her local chapter's board, and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her nine books can be found on Amazon.
Researchers identify Apex1 protein as a promising target for autoimmune disease treatment.
Children’s immune systems react differently to cancer, requiring tailored treatments and approaches.
Research shows that addressing teen mental health leads to improved economic and social outcomes in adulthood.
Researchers uncover potential therapy to enhance memory in neurodegenerative diseases.
East Palestine residents face delays and frustrations over train derailment compensation payments.
Multifocal contact lenses slow childhood myopia progression, with lasting benefits after discontinuation.
High-fat diets during adolescence disrupt brain development, reward systems, and impulsivity.
Green tea may reduce dementia risk by protecting the brain from damage.
Personalized heart condition diagnosis refines accuracy, especially for women.
Research shows biomarker testing reduces lung cancer deaths by 40% in smokers.